US House Bills Address Telemedicine, Prostate Cancer Tests, Diabetes Supplies
A slate of bills recently approved by the US House Energy and Commerce Health Subcommittee seek to give Medicare stroke beneficiaries better access to telemedicine, provide coverage of DNA-based prostate cancer tests, and make changes to CMS's competitive bidding program for durable medical equipment to ensure diabetic beneficiaries receive diabetes test strips.
You may also be interested in...
Medtech and funding provisions in a two-year budget deal that the US Senate and House approved early Friday morning and which were signed by the President would extend Medicate telehealth programs, remove a rental cap for speech-generating devices and strengthen competitive bidding rules to assure access to diabetic test strips, among others.
Under the gun and past a deadline, Senate and House authorizing committees managed to advance almost-identical bills extending funding for the US Children's Health Insurance Program (CHIP) to full-chamber votes. But no device tax repeal provisions came up amid other demanding political and fiscal priorities, and a Senate staffer says device-tax repeal may be too expensive.
Mobile health devices including wearable consumer products have the potential to collect a lot of medical information that can be useful for product development and tracking. A new action plan from US FDA, industry and other key players outlines ways to harness and use that data to bring better products to market more quickly.